United States Duodenoscopes Market Size, Share, and COVID-19 Impact Analysis, By Product (Reusable and Disposable), By Application (Diagnostics and Therapeutics/Treatment), and United States Duodenoscopes Market Insights, Industry Trend, Forecasts to 2035

United States Duodenoscopes Market Insights Forecasts to 2035

• The US Duodenoscopes Market Size Was Estimated at USD 668.7 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.53% from 2025 to 2035
• The US Duodenoscopes Market Size is Expected to Reach USD 1209.3 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United States Duodenoscopes Market is anticipated to reach USD 1209.3 million by 2035, growing at a CAGR of 5.53% from 2025 to 2035. The expansion of the United States duodenoscopes market is propelled by increasing rates of gastrointestinal illnesses, improvements in endoscopic technology, increased popularity of ERCP treatments, large R&D expenditures, and regulatory frameworks that are supportive.

Market Overview

A duodenoscope is a flexible, side-viewing endoscope inserted through the mouth and guided into the duodenum via the esophagus and stomach. It is primarily used during endoscopic retrograde cholangiopancreatography procedures to diagnose and treat diseases affecting the bile and pancreatic ducts. The increasing prevalence of gastrointestinal diseases, in particular cancers of the pancreas and bile ducts, is the major driver shaping the market growth. With the rising rate of diagnoses of gastrointestinal disorders, bile duct cancer, and pancreatic cancer, diagnostic tools like duodenoscopes will also need to expand. Technology advancement is essential to improve the efficiency and efficacy of duodenoscopes.  The market will grow during the forecast period based on the rising demand for flexible video duodenoscopes and the increasing prevalence of GI diseases. The demand for endoscopic retrograde cholangiopancreatography (ERCP) is driving the market.

The U.S. Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH), has led several efforts to lower the risk of infection from duodenoscopes used in ERCP procedures. Among these are safety notices that recommend hospitals utilise duodenoscopes with disposable parts or completely disposable scopes to reduce the danger of infection. These are mandated following the release of 522 surveillance studies that demonstrate high levels of contamination in fixed-endcap versions.

Report Coverage

This research report categorizes the market for the United States duodenoscopes market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States duodenoscopes market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States duodenoscopes market.

Driving Factors

The growth of the United States duodenoscopes market is boosted by the rising incidence of gastrointestinal infections, stomach cancer, bile duct cancer, and pancreatic cancer. Duodenoscopes may be used to assess the causes and risk factors of the disease. Moreover, the market is also growing due to increased research and development and technological improvements that are making duodenoscopes more effective in medical procedures.

Restraining Factors

The United States duodenoscopes market faces obstacles like regulatory practices in the production of duodenoscopes. In addition, the market could also be limited by the lengthy product clearance process and the availability of less expensive alternatives.

Market Segmentation

The United States duodenoscopes market share is classified into product and application.

• The reusable segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States duodenoscopes market is segmented by product into reusable and disposable. Among these, the reusable segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven because it is an essential tool for healthcare organisations looking to improve patient outcomes and procedural efficacy. Since reusable duodenoscopes can perform complex procedures involving the biliary and pancreatic systems, they have created new treatment pathways and facilitated improved clinical outcomes.

• The therapeutics/treatment segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the application, the United States duodenoscopes market is segmented into diagnostics and therapeutics/treatment. Among these, the therapeutics/treatment segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled as OC disorders like pancreatic cancer, bile duct obstructions, or chronic pancreatitis become more common; the demand for injectable devices and diagnostic and therapeutic devices like duodenoscopes has increased. The benefits and resultant advantages of minimally invasive procedures-having shorter recovery times and reduced complications relative to conventional surgical options-healthcare organisations which are more inclined to embrace minimally invasive procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States duodenoscopes market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Recent Development

• In May 2024, Advanced Sterilization Products (ASP) and PENTAX Medical collaborated to secure FDA clearance for the ULTRA GI Cycle, a hydrogen peroxide gas plasma sterilization mode for the STERRAD 100NX sterilizer. Developed specifically for duodenoscope reprocessing, this method exceeds previous cleaning standards and addresses longstanding contamination concerns.

List of Key Companies

• Fujifilm Holdings Corporation
• PENTAX Medical
• Karl Storz SE & Co. KG
• Ambu A/S
• Boston Scientific Corporation
• Cook Medical
• CONMED Corporation
• Medtronic plc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States duodenoscopes market based on the following segments:

United States Duodenoscopes Market, By Product

• Reusable
• Disposable

United States Duodenoscopes Market, By Application

• Diagnostics
• Therapeutics/Treatment